LUMACAFTOR AND IVACAFTOR

8538 reported adverse events

Drug classes: Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]

These side effects are most commonly reported by patients taking LUMACAFTOR AND IVACAFTOR:

# Side effect Count
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1462
1 HOSPITALISATION 888
2 DYSPNOEA 559
3 PULMONARY FUNCTION TEST DECREASED 397
4 COUGH 395
5 INFECTION 370
6 CHEST DISCOMFORT 344
7 CYSTIC FIBROSIS 328
8 PNEUMONIA 269
9 MALAISE 225
See all common reactions for LUMACAFTOR AND IVACAFTOR

LUMACAFTOR AND IVACAFTOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1462 0.2684
1 CYSTIC FIBROSIS LUNG 24 0.1875
2 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 162 0.1814
3 PULMONARY FUNCTION TEST DECREASED 397 0.0906
4 SWEAT TEST ABNORMAL 6 0.0882
5 CYSTIC FIBROSIS RELATED DIABETES 10 0.0685
6 DISTAL INTESTINAL OBSTRUCTION SYNDROME 23 0.0682
7 CYSTIC FIBROSIS 328 0.0592
8 FORCED EXPIRATORY VOLUME DECREASED 120 0.0423
9 INFECTIVE EXACERBATION OF BRONCHIECTASIS 12 0.0391
See all enriched reactions for LUMACAFTOR AND IVACAFTOR